All articles tagged with #zyn
Reports of US children under six ingesting flavored nicotine pouches have surged by 763% over three years, leading to serious health issues and two deaths, with concerns raised about their attractiveness to children due to flavors and marketing, and calls for better storage and prevention measures.
Sales of Zyn nicotine pouches are rapidly increasing in the U.S., driven by their discreet, smoke-free design and potential as a safer alternative to smoking, though concerns about youth appeal and addiction persist. The FDA has recently approved marketing for some Zyn products, and the company is expanding production, raising questions about regulation and public health impacts.
Philip Morris International is investing $600 million in a new Zyn nicotine pouch manufacturing facility in Aurora, Colorado, expected to create 500 local jobs and 5,000 construction jobs. The facility aims to meet the growing demand for smokeless nicotine alternatives and is projected to have a $550 million annual economic impact. The company also announced significant donations to support Colorado veterans and local housing initiatives. Concerns remain about the potential appeal of nicotine pouches to underage users, although current data shows low usage among teens.
Philip Morris International is investing $600 million to build a new production facility in Aurora, Colorado, to manufacture Zyn nicotine pouches, addressing nationwide shortages. The facility will create 500 direct jobs and have a significant economic impact. This move aligns with PMI's mission to provide better alternatives to traditional cigarettes.
Philip Morris International Inc. is investing $600 million in a new manufacturing facility in Aurora, Colorado, to increase production of Zyn, a popular oral nicotine pouch facing high demand. The plant will start operations by the end of next year, with regular production beginning in 2026.
Zyn nicotine pouches, a discreet and addictive alternative to cigarettes and vapes, have seen a surge in popularity, with sales exceeding 800 million units in the first three months of 2022. While some see potential for harm reduction, experts caution that there isn't enough data to know about the long-term effects of nicotine pouches as a way to quit smoking or vaping. Additionally, the tobacco industry's marketing of these products as "tobacco-free" can be misleading to consumers, and there are concerns about the potential for gum damage and other health risks associated with long-term use.